Emilie LAHAYE

Ms. Emilie LAHAYE

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VZVasiliy Zolotarev
Vasiliy Zolotarev
VMVladimir O. Murovets
Vladimir O. Murovets
ASAnastasiya L. Sepp
Anastasiya L. Sepp
ESEgor A. Sozontov
Egor A. Sozontov
ELEkaterina A. Lukina
Ekaterina A. Lukina
Sergueï O. FetissovSergueï O. Fetissov
Sergueï O. Fetissov
A commercial strain of Hafnia alvei (H. alvei) 4597 bacteria was shown to reduce food intake and promote weight loss, effects possibly induced by the bacterial protein ClpB, an antigen-mimetic of the anorexigenic α-melanocyte-stimulating hormone. A decrease in the basal plasma glucose levels was also observed in overweight fasted humans and mice receiving H. alvei. However, it is not known whether H. alvei influences sweet taste preference and whether its protein extract or ClpB are sufficient to increase glucose tolerance; these are the objectives tested in the present study. C57BL/6J male mice were kept under standard diet and were gavaged daily for 17 days with a suspension of H. alvei (4.5 × 107 CFU/animal) or with H. alvei total protein extract (5 μg/animal) or saline as a control. Sweet taste preference was analyzed via a brief-access licking test with sucrose solution. Glucose tolerance tests (GTT) were performed after the intraperitoneal (IP) or intragastric (IG) glucose administration at the 9th and 15th days of gavage, respectively. The expression of regulatory peptides’ mRNA levels was assayed in the hypothalamus. In another experiment performed in non-treated C57BL/6J male mice, effects of acute IP administration of recombinant ClpB protein on glucose tolerance were studied by both IP- and IG-GTT. Mice treated with the H. alvei protein extract showed an improved glucose tolerance in IP-GTT but not in IG-GTT. Both groups treated with H. alvei bacteria or protein extract showed a reduction of pancreatic tissue weight but without significant changes to basal plasma insulin. No significant effects of H. alvei bacteria or its total protein extract administration were observed on the sweet taste preference, insulin tolerance and expression of regulatory peptides’ mRNA in the hypothalamus. Acute administration of ClpB in non-treated mice increased glucose tolerance during the IP-GTT but not the IG-GTT, and reduced basal plasma glucose levels. We conclude that both the H. alvei protein extract introduced orally and the ClpB protein administered via IP improve glucose tolerance probably by acting at the glucose postabsorptive level. Moreover, H. alvei probiotic does not seem to influence the sweet taste preference. These results justify future testing of both the H. alvei protein extract and ClpB protein in animal models of diabetes.

31 January 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
HVHenning Vaeroy
Henning Vaeroy
STSaloua Takhlidjt
Saloua Takhlidjt
YCYamina Cherifi
Yamina Cherifi
ELEmilie LAHAYE
Emilie LAHAYE
NCNicolas Chartrel
Nicolas Chartrel
Sergueï O. FetissovSergueï O. Fetissov
Sergueï O. Fetissov
26RFa, also referred to as QRFP, is a hypothalamic neuropeptide mainly known for its role in the regulation of appetite and glucose metabolism. Its possible relevance to emotional regulation is largely unexplored. To address this, in the present exploratory study, we analyzed the plasma concentrations of 26RFa in humans characterized by different levels of anxiety and aggressive behavior. For this purpose, the study included 13 prison inmates who have committed violent crimes and 19 age-matched healthy men from the general population as controls. Anxiety, depression and aggressive behavior were evaluated in both groups using standard questionnaires. The inmate group was characterized by increased aggression and anxiety compared to the controls. We found that the mean plasma levels of 26RFa did not significantly differ between the inmates and the controls. However, several high outliers were present only in the inmate group. The plasma levels of 26RFa correlated positively with the anxiety scores in all the studied subjects and controls. After removing the high outliers in the inmate group, positive correlations of 26RFa with anxiety and a subscale of hostility in the aggression scale were also recorded in this group. No significant correlations of 26RFa with depression scores or other parameters of aggressive behavior were found. Thus, the present results did not support an involvement of 26RFa in aggressive behavior in humans but pointed to a link between this neuropeptide and anxiety. Nevertheless, considering the exploratory nature of the present study, this conclusion should be verified in a larger cohort, including the clinical degree of anxiety.

13 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJules Balanche
Jules Balanche
ELEmilie LAHAYE
Emilie LAHAYE
LBLisa Bremard
Lisa Bremard
BTBenjamin Thomas
Benjamin Thomas
Sergueï O. FetissovSergueï O. Fetissov
Sergueï O. Fetissov
Before the absorption in the intestine, glucose encounters gut bacteria, which may serve as a barrier against hyperglycemia by metabolizing glucose. In the present study, we compared the capacity of enterobacterial strains to lower glucose levels in an in vitro model of nutrient-induced bacterial growth. Two probiotic strains, Hafnia alvei HA4597 (H. alvei) and Escherichia coli (E. coli) Nissle 1917, as well as E. coli K12, were studied. To mimic bacterial growth in the gut, a planktonic culture was supplemented twice daily by the Luria Bertani milieu with or without 0.5% glucose. Repeated nutrient provision resulted in the incremental growth of bacteria. However, in the presence of glucose, the maximal growth of both strains of E. coli but not of H. alvei was inhibited. When glucose was added to the culture medium, a continuous decrease in its concentration was observed during each feeding phase. At its highest density, H. alvei displayed more efficient glucose consumption accompanied by a more pronounced downregulation of glucose transporters’ expression than E. coli K12. Thus, the study reveals that the probiotic strain H. alvei HA4597 is more resilient to maintain its growth than E. coli in the presence of 0.5% glucose accompanied by more efficient glucose consumption. This experimental approach offers a new strategy for the identification of probiotics with increased glucose metabolizing capacities potentially useful for the prevention and co-treatment of type 2 diabetes.

9 April 2026
Verified
Thesis
Closed access
ELEmilie LAHAYE
Emilie LAHAYE
Les troubles liés au stress incluent diverses conditions pathologiques avec le stress comme facteur de risque majeur. Ils sont caractérisés par une suractivation de l'axe hypothalamo-hypophyso-surrénalien (HPA) régulant la réponse au stress. Une activation chronique de l'axe HPA dans des maladies telles que l'anorexie mentale et la dépression majeure entraîne une sécrétion excessive de cortisol, contribuant à des anomalies métaboliques, immunitaires et comportementales. L'ocytocine (OT), un neuropeptide hypothalamique, a un effet anti-stress en réduisant l’activité de l’axe HPA. Un comportement social anormal, comme l’agressivité, peut également être lié à une hyper- ou hypo-activation de l'axe du stress. Les troubles du spectre autistique (TSA) sont des troubles neurodéveloppementaux caractérisés par des difficultés de communication sociale. Les TSA représentent un problème de santé publique en raison de leur prévalence élevée et de leur persistance. Les mécanismes étiologiques des TSA sont mal compris, mais des altérations du système ocytocinergique et une dysbiose du microbiote intestinal sont observées. En effet, l’OT facilite les comportements sociaux et constitue une cible moléculaire pour les troubles liés au stress et autistiques. Des immunoglobulines G (IgG) réactives à l'OT ont été détectées dans le plasma humain, cependant, leur mécanisme d'action et leur origine restent inconnus, ce qui constitue les questions principales de mon projet de thèse. Ces travaux ont mis en évidence un rôle des IgG comme une molécule porteuse de l’OT dans la circulation sanguine. De plus, avec une affinité plus faible pour ce peptide, des IgG ont une capacité de transport réduite ainsi qu’une activation du récepteur plus faible chez des sujets agressifs. Nous avons émis l'hypothèse que certaines bactéries intestinales pourraient produire des protéines antigéniques présentant un mimétisme moléculaire avec l'OT et stimuler la production d’IgG réactives au peptide. Cela pourrait moduler la signalisation de l'OT et être pertinent pour la physiopathologie et le traitement des troubles liés au stress et des TSA. En utilisant une approche protéomique, nous avons observé que plusieurs espèces de Lactobacillus (L.) présentent des niveaux accrus d'immunoréactivité similaire à l'OT par rapport à E. coli. Ensuite, en utilisant la spectrométrie de masse, trois protéines bactériennes potentielles similaires à l'OT ont été identifiées dans L. salivarius. Une immunisation avec ces protéines recombinantes induit une augmentation des taux plasmatiques d’IgG réactifs à l’OT ainsi que les taux hypothalamiques d’OT. Ce traitement réalisé chez des souris BTBR, un modèle d’étude des TSA, a amélioré la sociabilité et diminué les comportements anxieux et hyperactifs avec un effet sexe-dépendant plus présent chez les mâles. Ainsi ces résultats ont mis en lumière que les lactobacilles produisent des protéines capables d’influencer la signalisation ocytocinergique. Ces résultats ouvrent des perspectives diagnostiques et thérapeutiques pour les troubles du stress et autistiques via une modulation du microbiote intestinal et la réponse immunitaire aux antigènes bactériennes spécifiques.